Skip to main navigation Skip to search Skip to main content

Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial (Nature Medicine, (2025), 31, 7, (2365-2374), 10.1038/s41591-025-03650-6)

  • Martin Wermke
  • , Dejka M. Araujo
  • , Manik Chatterjee
  • , Apostolia M. Tsimberidou
  • , Tobias A.W. Holderried
  • , Amir A. Jazaeri
  • , Ran Reshef
  • , Carsten Bokemeyer
  • , Winfried Alsdorf
  • , Katrin Wetzko
  • , Peter Brossart
  • , Katrin Aslan
  • , Linus Backert
  • , Sebastian Bunk
  • , Jens Fritsche
  • , Swapna Gulde
  • , Silvana Hengler
  • , Norbert Hilf
  • , Mohammad B. Hossain
  • , Jens Hukelmann
  • Mamta Kalra, Delfi Krishna, M. Alper Kursunel, Dominik Maurer, Andrea Mayer-Mokler, Regina Mendrzyk, Ali Mohamed, Karine Pozo, Arun Satelli, Marilena Letizia, Heiko Schuster, Oliver Schoor, Claudia Wagner, Hans Georg Rammensee, Carsten Reinhardt, Harpreet Singh-Jasuja, Steffen Walter, Toni Weinschenk, Jason J. Luke, Cedrik M. Britten

Research output: Contribution to journalComment/debatepeer-review

Abstract

Correction to: Nature Medicinehttps://doi.org/10.1038/s41591-025-03650-6, published online 9 April 2025. In the version of the article initially published, the surname of Dejka M. Araujo was misspelled (as Araurjo), while Extended Data Fig. 9 was a duplicate of Extended Data Fig. 8; the name and figure have now been updated in the HTML and PDF versions of the article.

Original languageEnglish (US)
Pages (from-to)2453
Number of pages1
JournalNature medicine
Volume31
Issue number7
DOIs
StatePublished - Jul 2025

ASJC Scopus subject areas

  • General Biochemistry, Genetics and Molecular Biology

Fingerprint

Dive into the research topics of 'Author Correction: Autologous T cell therapy for PRAME+ advanced solid tumors in HLA-A*02+ patients: a phase 1 trial (Nature Medicine, (2025), 31, 7, (2365-2374), 10.1038/s41591-025-03650-6)'. Together they form a unique fingerprint.

Cite this